v3.23.1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenues $ 16,748 $ 20,605
Cost of goods sold 6,074 6,410
Gross profit 10,674 14,195
Operating Expenses:    
General and administrative 21,127 25,317
Severance and restructuring costs 466 0
Research and development 2,905 4,447
Gain on acquisition contingency (1,066) (8,503)
Asset impairment and abandonments 553 939
Transaction and financing expenses 463 916
Total operating expenses 24,448 23,116
Gain on sale of Coflex (12,631) 0
Operating loss (1,143) (8,921)
Other (income) expense - net    
Other (income) expense - net (147) 28
Interest expense 252 252
Foreign exchange (gain) loss (238) 353
Change in fair value of warrant liability (5,288) (9,743)
Total other (income) - net (5,421) (9,110)
Income before income tax provision 4,278 189
Income tax provision 133 162
Net income from operations 4,145 27
Other comprehensive income (loss)    
Unrealized foreign currency translation (gain) (509) (109)
Total other comprehensive income $ 4,654 $ 136
Net income per common share - basic (in dollars per share) $ 0.51 $ 0.00
Net income per common share - diluted (in dollars per share) $ (0.03) $ 0.00
Weighted average shares outstanding - basic (in shares) 8,072,339 5,733,646
Weighted average shares outstanding - diluted (in shares) 13,320,439 5,910,719

Source